$PULM 4 SEC Filings

Filed On	Filing
30 Jan 2023	Form 4: Siegert Michelle, Vice President, Finance Granted 9,900 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Wasilewski Margaret, Chief Medical Officer Granted 11,400 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Raad Teofilo David, Director Granted 34,900 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Bazemore Todd, Director Granted 1,700 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Higgins Michael J, Director Granted 2,436 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Cabell Christopher, Director Granted 1,700 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Varadan Anand, Director Granted 1,700 Stock Option (Right to Buy)
30 Jan 2023	Form 4: Batycky Richard P., Director Granted 1,700 Stock Option (Right to Buy)
03 Mar 2022	Form 4: Wasilewski Margaret, Chief Medical Officer Granted 21,060 Stock Option (Right to Buy)
31 Jan 2022	Form 4: Higgins Michael J, Director Granted 36,833 Stock Option (Right to Buy)
31 Jan 2022	Form 4: Batycky Richard P., Director Granted 22,100 Stock Option (Right to Buy)
31 Jan 2022	Form 4: Cabell Christopher, Director Granted 22,100 Stock Option (Right to Buy)
28 Jan 2022	Form 4: Bazemore Todd, Director Granted 22,100 Stock Option (Right to Buy)
28 Jan 2022	Form 4: Varadan Anand, Director Granted 22,100 Stock Option (Right to Buy)
28 Jan 2022	Form 4: Siegert Michelle, Vice President, Finance Granted 184,300 Stock Option (Right to Buy)
28 Jan 2022	Form 4: Raad Teofilo David, Director Granted 750,000 Stock Option (Right to Buy)
28 Jul 2021	Form 4: Varadan Anand, Director Granted 30,000 Stock Option (Right to Buy)
01 Feb 2021	Form 4: Munshi Amit, Director Granted 15,000 Stock Option (Right to Buy)
01 Feb 2021	Form 4: Iwicki Mark T, Director Granted 15,000 Stock Option (Right to Buy)
01 Feb 2021	Form 4: Cabell Christopher, Director Granted 15,000 Stock Option (Right to Buy)

Comments